Dentists in Ratcliff, AR Accepting Medicare
3 Dentists found. Showing 1 - 3
 Edward A Vela, DDS Dentist Medicare: Medicare Enrolled Practice Location: 9755 W State Hwy 22, Ratcliff, AR 72951 Phone: 479-635-5300 Fax: 479-635-4700 |
Thomas Donovan Kiefer, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 9755 W State Highway 22, Ratcliff, AR 72951 Phone: 479-635-5300 |
Dr. Sam R. Shanlever, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 9755 W State Highway 22, Ratcliff, AR 72951 Phone: 479-635-5300 Fax: 479-635-2010 |
News Archive
Galangin mediates apoptosis of hepatocellular carcinoma cells through mitochondrial pathway: Study
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, particularly in China. However, HCC remains one of the more difficult cancers to treat. It is important to screen for new anti-cancer drugs. A number of dietary compounds possess anti-cancer properties. These dietary compounds may modify the activity of specific targets that control cell proliferation and apoptosis. Galangin could inhibit the methoxyresorufin O-demethylase activity of CYP1A2, CYP1A1 and P-form phenolsulfotransferase.
California lawmakers raising smoking age to curb teen smoking
With California lawmakers voting this month to raise the minimum age to buy tobacco products from 18 to 21 years of age, questions are being raised about its impact. Although much of the discussion of the policy has centered on the 18 to 20 year-olds who will no longer be able to buy cigarettes, the real focus should be its potential to keep cigarettes away from high school students 14 to 17 years old, said John Billimek, a researcher with the Health Policy Research Institute in the UC Irvine School of Medicine.
AMT reports positive preclinical data from cholesterol targeting AAV gene therapy study
Amsterdam Molecular Therapeutics a world leader in gene therapy, today reported positive preclinical data from a study using an AAV gene therapy product to lower cholesterol.
Sigma-Aldrich declares quarterly cash dividend of $.18 per share
Sigma-Aldrich - At the Board of Directors meeting held today, the Directors declared a quarterly cash dividend of $.18 per share. The dividend is payable on December 15, 2011 to shareholders of record on December 1, 2011.
St. Jude Medical completes second interoperability testing process for Merlin.net Patient Care Network
St. Jude Medical, Inc. today announced it has successfully completed its second interoperability testing process for the company's Merlin.net™ Patient Care Network, an Internet-based repository of patient and implantable device data.
› Verified 7 days ago